M&A Deal Summary

Abbott Laboratories Acquires CFR Pharmaceuticals S.A.

On May 16, 2014, Abbott Laboratories acquired life science company CFR Pharmaceuticals S.A. for 2.9B USD

Acquisition Highlights
  • This is Abbott Laboratories’ 10th transaction in the Life Science sector.
  • This is Abbott Laboratories’ 8th largest (disclosed) transaction.
  • This is Abbott Laboratories’ 1st transaction in Chile.

M&A Deal Summary

Date 2014-05-16
Target CFR Pharmaceuticals S.A.
Sector Life Science
Buyer(s) Abbott Laboratories
Deal Type Add-on Acquisition
Deal Value 2.9B USD

Target

CFR Pharmaceuticals S.A.

Providencia,, Chile
CFR Pharmaceuticals S.A. is engaged in the research, development, production, and sale of specialty generic medicines and complex injectables.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States

Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.


DEAL STATS #
Overall 25 of 35
Sector (Life Science) 10 of 11
Type (Add-on Acquisition) 25 of 35
Country (Chile) 1 of 1
Year (2014) 1 of 3
Size (of disclosed) 8 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-19 OptiMedica

Santa Clara, California, United States

OptiMedica Corp. is an ophthalmic device company.

Buy $250M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-23 Veropharm

Moscow, Russia

Veropharm is a Russian pharmaceutical producer known in Russia and abroad as one of Russia’s major manufacturers of generic drugs that are identical to their brand name counterparts, oncological medications, and medical adhesive bandages.

Buy $305M